chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac arrest, Cardiac failure congestive, Chronic obstructive pulmonary disease, Chronic respiratory failure, Complication of device insertion
Clinical narrative: Narrative:  68yo male Pt - H&R per Md note on admission on 12/22/2021 "CC:acute on chronic hypoxic hypercarbic respiratory failure 68y.o.  MALE with h/o HGpEF (EF 45% in 2017), COPD on 2L O2, morbid obesity, HTN, HLD, IDDM2, OSA and anxiety presents as a transfer from  Hospital for acute on chronic hypoxic/hypercarbic respiratory failure.  Patient is intubated and sedated so history obtained via outside records and patient's wife. Patient's wife states that for the past month he has  had difficulty waking in the morning taking 1-1.5 hours to wake up then over the  last few days started complaining of progressive shortness of air. She checked his  O2 sats at home and was found to be 75% so called EMS and was taken to  Hospital. She denies any recent fever, chills or cough. Does endorse orthopnea and sleeps in a hospital bed at home as well as progressive LE edema for the last 1-2 months. He was admitted for COPD and CHF exacerbation 1 month prior. On arrival to hospital on 12/20 he was somnolent with ABG showing 7.25/85/82/36 on 7L. He was started on IV steroids, duonebs as well as diuretics with concern for COPD exacerbation vs decompensated HF. He was started on BIPAP with minimal improvement so elected for intubation. First intubation  attempt was unsuccessful and patient became bradycardic and went into asystole arrest. He received 3 of epi, 1 of atropine and was eventually intubated and ROSC obtained and he was transferred to Specialist Hospital as multiple other hospitals refused  him due to limited ICU beds. Medical Hx: HFpEF (EF 50% in 2017), COPD on  2L O2, CAD, morbid obesity, HTN, HLD, IDDM2, OSA and anxiety Surgical Hx: Gastric bypass, cardiac catheterization w/ 90% occlusion of L circumflex w/ angioplasty 2015" Pt was admitted to ICU at hospital on  12/22/2021. Pt then died on 12/25/2021 during this admission. "Death was caused by: Severe Anoxic brain injury 2/2 AHRF" per Md death note. Per MD note on 12/25/2021 "Assess:Anoxic encephalopathy 2o to cardiac arrest during attempted intubation at Hospital". Pt had received covid vaccines on 2/26/2021 & 3/26/21. This death is not related to covid vaccines.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Death, Dyspnoea, Endotracheal intubation, Hypercapnia
Clinical narrative: Narrative:  68yo male Pt - H&R per Md note on admission on 12/22/2021 "CC:acute on chronic hypoxic hypercarbic respiratory failure 68y.o.  MALE with h/o HGpEF (EF 45% in 2017), COPD on 2L O2, morbid obesity, HTN, HLD, IDDM2, OSA and anxiety presents as a transfer from  Hospital for acute on chronic hypoxic/hypercarbic respiratory failure.  Patient is intubated and sedated so history obtained via outside records and patient's wife. Patient's wife states that for the past month he has  had difficulty waking in the morning taking 1-1.5 hours to wake up then over the  last few days started complaining of progressive shortness of air. She checked his  O2 sats at home and was found to be 75% so called EMS and was taken to  Hospital. She denies any recent fever, chills or cough. Does endorse orthopnea and sleeps in a hospital bed at home as well as progressive LE edema for the last 1-2 months. He was admitted for COPD and CHF exacerbation 1 month prior. On arrival to hospital on 12/20 he was somnolent with ABG showing 7.25/85/82/36 on 7L. He was started on IV steroids, duonebs as well as diuretics with concern for COPD exacerbation vs decompensated HF. He was started on BIPAP with minimal improvement so elected for intubation. First intubation  attempt was unsuccessful and patient became bradycardic and went into asystole arrest. He received 3 of epi, 1 of atropine and was eventually intubated and ROSC obtained and he was transferred to Specialist Hospital as multiple other hospitals refused  him due to limited ICU beds. Medical Hx: HFpEF (EF 50% in 2017), COPD on  2L O2, CAD, morbid obesity, HTN, HLD, IDDM2, OSA and anxiety Surgical Hx: Gastric bypass, cardiac catheterization w/ 90% occlusion of L circumflex w/ angioplasty 2015" Pt was admitted to ICU at hospital on  12/22/2021. Pt then died on 12/25/2021 during this admission. "Death was caused by: Severe Anoxic brain injury 2/2 AHRF" per Md death note. Per MD note on 12/25/2021 "Assess:Anoxic encephalopathy 2o to cardiac arrest during attempted intubation at Hospital". Pt had received covid vaccines on 2/26/2021 & 3/26/21. This death is not related to covid vaccines.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxic-ischaemic encephalopathy, Intensive care, Oedema peripheral, Orthopnoea, Positive airway pressure therapy
Clinical narrative: Narrative:  68yo male Pt - H&R per Md note on admission on 12/22/2021 "CC:acute on chronic hypoxic hypercarbic respiratory failure 68y.o.  MALE with h/o HGpEF (EF 45% in 2017), COPD on 2L O2, morbid obesity, HTN, HLD, IDDM2, OSA and anxiety presents as a transfer from  Hospital for acute on chronic hypoxic/hypercarbic respiratory failure.  Patient is intubated and sedated so history obtained via outside records and patient's wife. Patient's wife states that for the past month he has  had difficulty waking in the morning taking 1-1.5 hours to wake up then over the  last few days started complaining of progressive shortness of air. She checked his  O2 sats at home and was found to be 75% so called EMS and was taken to  Hospital. She denies any recent fever, chills or cough. Does endorse orthopnea and sleeps in a hospital bed at home as well as progressive LE edema for the last 1-2 months. He was admitted for COPD and CHF exacerbation 1 month prior. On arrival to hospital on 12/20 he was somnolent with ABG showing 7.25/85/82/36 on 7L. He was started on IV steroids, duonebs as well as diuretics with concern for COPD exacerbation vs decompensated HF. He was started on BIPAP with minimal improvement so elected for intubation. First intubation  attempt was unsuccessful and patient became bradycardic and went into asystole arrest. He received 3 of epi, 1 of atropine and was eventually intubated and ROSC obtained and he was transferred to Specialist Hospital as multiple other hospitals refused  him due to limited ICU beds. Medical Hx: HFpEF (EF 50% in 2017), COPD on  2L O2, CAD, morbid obesity, HTN, HLD, IDDM2, OSA and anxiety Surgical Hx: Gastric bypass, cardiac catheterization w/ 90% occlusion of L circumflex w/ angioplasty 2015" Pt was admitted to ICU at hospital on  12/22/2021. Pt then died on 12/25/2021 during this admission. "Death was caused by: Severe Anoxic brain injury 2/2 AHRF" per Md death note. Per MD note on 12/25/2021 "Assess:Anoxic encephalopathy 2o to cardiac arrest during attempted intubation at Hospital". Pt had received covid vaccines on 2/26/2021 & 3/26/21. This death is not related to covid vaccines.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory failure, Somnolence
Clinical narrative: Narrative:  68yo male Pt - H&R per Md note on admission on 12/22/2021 "CC:acute on chronic hypoxic hypercarbic respiratory failure 68y.o.  MALE with h/o HGpEF (EF 45% in 2017), COPD on 2L O2, morbid obesity, HTN, HLD, IDDM2, OSA and anxiety presents as a transfer from  Hospital for acute on chronic hypoxic/hypercarbic respiratory failure.  Patient is intubated and sedated so history obtained via outside records and patient's wife. Patient's wife states that for the past month he has  had difficulty waking in the morning taking 1-1.5 hours to wake up then over the  last few days started complaining of progressive shortness of air. She checked his  O2 sats at home and was found to be 75% so called EMS and was taken to  Hospital. She denies any recent fever, chills or cough. Does endorse orthopnea and sleeps in a hospital bed at home as well as progressive LE edema for the last 1-2 months. He was admitted for COPD and CHF exacerbation 1 month prior. On arrival to hospital on 12/20 he was somnolent with ABG showing 7.25/85/82/36 on 7L. He was started on IV steroids, duonebs as well as diuretics with concern for COPD exacerbation vs decompensated HF. He was started on BIPAP with minimal improvement so elected for intubation. First intubation  attempt was unsuccessful and patient became bradycardic and went into asystole arrest. He received 3 of epi, 1 of atropine and was eventually intubated and ROSC obtained and he was transferred to Specialist Hospital as multiple other hospitals refused  him due to limited ICU beds. Medical Hx: HFpEF (EF 50% in 2017), COPD on  2L O2, CAD, morbid obesity, HTN, HLD, IDDM2, OSA and anxiety Surgical Hx: Gastric bypass, cardiac catheterization w/ 90% occlusion of L circumflex w/ angioplasty 2015" Pt was admitted to ICU at hospital on  12/22/2021. Pt then died on 12/25/2021 during this admission. "Death was caused by: Severe Anoxic brain injury 2/2 AHRF" per Md death note. Per MD note on 12/25/2021 "Assess:Anoxic encephalopathy 2o to cardiac arrest during attempted intubation at Hospital". Pt had received covid vaccines on 2/26/2021 & 3/26/21. This death is not related to covid vaccines.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Neuropathy peripheral, Osteoarthritis
Clinical narrative: Narrative: 51yo male pt with: PMH: Essential tremor Alcoholic fatty liver  Osteoarthritis of first metatarsophalangLipoma  Carpal Tunnel Syndrome (ICD-9-CM 354.0) Ganglion of joint (ICD-9-CM 727.41) Essential hypertension Health Maintenance (ICD-9-CM V65.9) Ulnar Neuropathy (ICD-9-CM 354.2) Tobacco user Degeneration of cervical intervertebral Gastroesophageal reflux disease Adjustment Disorder Unspecified (ICD-9-C Received covid vaccines /on 3/17/2021 & 2/17/2021. Pt died on 11/18/2021. No information given on cause of death. Likely death is not related to covid vaccines due to long time distance between date of death and ate vaccines were given.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Agitation, Atrial fibrillation, Blood bicarbonate decreased, Blood chloride decreased, Blood culture
Clinical narrative: Narrative:  Patient presented to the ED via EMS on 12/29/2021 with a chief complaint of vomiting x 24 hours. He reported testing positive for COVID on a home test. Symptoms began about 12/26/2021. EMS reported normal blood glucose and atrial fibrillation with HR sustaining in 120s. On arrival to our ED, Patient was saturating 86% on room air He was febrile (T 99.8) and tachycardic (HR 127). Labs in ED revealed leukopenia (WBC 2.80), thrombocytopenia (PLT 92), mild DKA (Glu 222mg/dL, bicarb 20.8mmol/L, AG 14.9, beta-hydroxybutyrate 0.5mmol/L), hyponatremia (Na 131mmol/L), hypochloremia (Cl 95.3mmol/L), elevated CRP (19.49), elevated d-dimer (0.5), elevated ferritin (714.4), and negative lactate. ABG on 2LPM via nasal cannula revealed hypoxic respiratory failure (pH 7.46, pCO2 34, pO2 62). COVID test was POSITIVE. CXR revealed multifocal peripheral patchy airspace opacities. Blood cultures were obtained. Patient was given LR x 1L, acetaminophen 1000mg IV x 1, and ondansetron 4mg IVP x 2. He was admitted to ICU for further care. Update of present Illness: 1/3/2022 - Remdesivir and dexamethasone were initiated. Levofloxacin was initiated for empiric CAP coverage. BIPAP was placed on 12/30/2021. FiO2 requirements have increased to 100%. Patient is BIPAP dependent this AM. 1/4/2022 - Remdesivir and levofloxacin completed. Dexamethasone continued. Patient remains BIPAP dependent this AM. Dexmedetomidine initiated for agitation with improvement in symptoms.  1/5/2022 - Patient desaturates with the removal of BIPAP.  Transition to comfort care is being considered. 1/6/2022 - Patient was transitioned to comfort care. Morphine IVP initiated. BIPAP removed. Patient progressed to asystole at 1240.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Blood gases abnormal, Blood glucose increased, Blood ketone body, Blood lactic acid normal, Blood pH increased
Clinical narrative: Narrative:  Patient presented to the ED via EMS on 12/29/2021 with a chief complaint of vomiting x 24 hours. He reported testing positive for COVID on a home test. Symptoms began about 12/26/2021. EMS reported normal blood glucose and atrial fibrillation with HR sustaining in 120s. On arrival to our ED, Patient was saturating 86% on room air He was febrile (T 99.8) and tachycardic (HR 127). Labs in ED revealed leukopenia (WBC 2.80), thrombocytopenia (PLT 92), mild DKA (Glu 222mg/dL, bicarb 20.8mmol/L, AG 14.9, beta-hydroxybutyrate 0.5mmol/L), hyponatremia (Na 131mmol/L), hypochloremia (Cl 95.3mmol/L), elevated CRP (19.49), elevated d-dimer (0.5), elevated ferritin (714.4), and negative lactate. ABG on 2LPM via nasal cannula revealed hypoxic respiratory failure (pH 7.46, pCO2 34, pO2 62). COVID test was POSITIVE. CXR revealed multifocal peripheral patchy airspace opacities. Blood cultures were obtained. Patient was given LR x 1L, acetaminophen 1000mg IV x 1, and ondansetron 4mg IVP x 2. He was admitted to ICU for further care. Update of present Illness: 1/3/2022 - Remdesivir and dexamethasone were initiated. Levofloxacin was initiated for empiric CAP coverage. BIPAP was placed on 12/30/2021. FiO2 requirements have increased to 100%. Patient is BIPAP dependent this AM. 1/4/2022 - Remdesivir and levofloxacin completed. Dexamethasone continued. Patient remains BIPAP dependent this AM. Dexmedetomidine initiated for agitation with improvement in symptoms.  1/5/2022 - Patient desaturates with the removal of BIPAP.  Transition to comfort care is being considered. 1/6/2022 - Patient was transitioned to comfort care. Morphine IVP initiated. BIPAP removed. Patient progressed to asystole at 1240.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Blood sodium decreased, C-reactive protein increased, COVID-19, Cardiac arrest, Chest X-ray abnormal
Clinical narrative: Narrative:  Patient presented to the ED via EMS on 12/29/2021 with a chief complaint of vomiting x 24 hours. He reported testing positive for COVID on a home test. Symptoms began about 12/26/2021. EMS reported normal blood glucose and atrial fibrillation with HR sustaining in 120s. On arrival to our ED, Patient was saturating 86% on room air He was febrile (T 99.8) and tachycardic (HR 127). Labs in ED revealed leukopenia (WBC 2.80), thrombocytopenia (PLT 92), mild DKA (Glu 222mg/dL, bicarb 20.8mmol/L, AG 14.9, beta-hydroxybutyrate 0.5mmol/L), hyponatremia (Na 131mmol/L), hypochloremia (Cl 95.3mmol/L), elevated CRP (19.49), elevated d-dimer (0.5), elevated ferritin (714.4), and negative lactate. ABG on 2LPM via nasal cannula revealed hypoxic respiratory failure (pH 7.46, pCO2 34, pO2 62). COVID test was POSITIVE. CXR revealed multifocal peripheral patchy airspace opacities. Blood cultures were obtained. Patient was given LR x 1L, acetaminophen 1000mg IV x 1, and ondansetron 4mg IVP x 2. He was admitted to ICU for further care. Update of present Illness: 1/3/2022 - Remdesivir and dexamethasone were initiated. Levofloxacin was initiated for empiric CAP coverage. BIPAP was placed on 12/30/2021. FiO2 requirements have increased to 100%. Patient is BIPAP dependent this AM. 1/4/2022 - Remdesivir and levofloxacin completed. Dexamethasone continued. Patient remains BIPAP dependent this AM. Dexmedetomidine initiated for agitation with improvement in symptoms.  1/5/2022 - Patient desaturates with the removal of BIPAP.  Transition to comfort care is being considered. 1/6/2022 - Patient was transitioned to comfort care. Morphine IVP initiated. BIPAP removed. Patient progressed to asystole at 1240.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Device dependence, Diabetic ketoacidosis, Fibrin D dimer, Fraction of inspired oxygen, Hypochloraemia
Clinical narrative: Narrative:  Patient presented to the ED via EMS on 12/29/2021 with a chief complaint of vomiting x 24 hours. He reported testing positive for COVID on a home test. Symptoms began about 12/26/2021. EMS reported normal blood glucose and atrial fibrillation with HR sustaining in 120s. On arrival to our ED, Patient was saturating 86% on room air He was febrile (T 99.8) and tachycardic (HR 127). Labs in ED revealed leukopenia (WBC 2.80), thrombocytopenia (PLT 92), mild DKA (Glu 222mg/dL, bicarb 20.8mmol/L, AG 14.9, beta-hydroxybutyrate 0.5mmol/L), hyponatremia (Na 131mmol/L), hypochloremia (Cl 95.3mmol/L), elevated CRP (19.49), elevated d-dimer (0.5), elevated ferritin (714.4), and negative lactate. ABG on 2LPM via nasal cannula revealed hypoxic respiratory failure (pH 7.46, pCO2 34, pO2 62). COVID test was POSITIVE. CXR revealed multifocal peripheral patchy airspace opacities. Blood cultures were obtained. Patient was given LR x 1L, acetaminophen 1000mg IV x 1, and ondansetron 4mg IVP x 2. He was admitted to ICU for further care. Update of present Illness: 1/3/2022 - Remdesivir and dexamethasone were initiated. Levofloxacin was initiated for empiric CAP coverage. BIPAP was placed on 12/30/2021. FiO2 requirements have increased to 100%. Patient is BIPAP dependent this AM. 1/4/2022 - Remdesivir and levofloxacin completed. Dexamethasone continued. Patient remains BIPAP dependent this AM. Dexmedetomidine initiated for agitation with improvement in symptoms.  1/5/2022 - Patient desaturates with the removal of BIPAP.  Transition to comfort care is being considered. 1/6/2022 - Patient was transitioned to comfort care. Morphine IVP initiated. BIPAP removed. Patient progressed to asystole at 1240.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Hyponatraemia, Intensive care, Leukopenia, Lung opacity, Malaise
Clinical narrative: Narrative:  Patient presented to the ED via EMS on 12/29/2021 with a chief complaint of vomiting x 24 hours. He reported testing positive for COVID on a home test. Symptoms began about 12/26/2021. EMS reported normal blood glucose and atrial fibrillation with HR sustaining in 120s. On arrival to our ED, Patient was saturating 86% on room air He was febrile (T 99.8) and tachycardic (HR 127). Labs in ED revealed leukopenia (WBC 2.80), thrombocytopenia (PLT 92), mild DKA (Glu 222mg/dL, bicarb 20.8mmol/L, AG 14.9, beta-hydroxybutyrate 0.5mmol/L), hyponatremia (Na 131mmol/L), hypochloremia (Cl 95.3mmol/L), elevated CRP (19.49), elevated d-dimer (0.5), elevated ferritin (714.4), and negative lactate. ABG on 2LPM via nasal cannula revealed hypoxic respiratory failure (pH 7.46, pCO2 34, pO2 62). COVID test was POSITIVE. CXR revealed multifocal peripheral patchy airspace opacities. Blood cultures were obtained. Patient was given LR x 1L, acetaminophen 1000mg IV x 1, and ondansetron 4mg IVP x 2. He was admitted to ICU for further care. Update of present Illness: 1/3/2022 - Remdesivir and dexamethasone were initiated. Levofloxacin was initiated for empiric CAP coverage. BIPAP was placed on 12/30/2021. FiO2 requirements have increased to 100%. Patient is BIPAP dependent this AM. 1/4/2022 - Remdesivir and levofloxacin completed. Dexamethasone continued. Patient remains BIPAP dependent this AM. Dexmedetomidine initiated for agitation with improvement in symptoms.  1/5/2022 - Patient desaturates with the removal of BIPAP.  Transition to comfort care is being considered. 1/6/2022 - Patient was transitioned to comfort care. Morphine IVP initiated. BIPAP removed. Patient progressed to asystole at 1240.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Medical device removal, Oxygen saturation decreased, PCO2 decreased, PO2 decreased, Platelet count decreased
Clinical narrative: Narrative:  Patient presented to the ED via EMS on 12/29/2021 with a chief complaint of vomiting x 24 hours. He reported testing positive for COVID on a home test. Symptoms began about 12/26/2021. EMS reported normal blood glucose and atrial fibrillation with HR sustaining in 120s. On arrival to our ED, Patient was saturating 86% on room air He was febrile (T 99.8) and tachycardic (HR 127). Labs in ED revealed leukopenia (WBC 2.80), thrombocytopenia (PLT 92), mild DKA (Glu 222mg/dL, bicarb 20.8mmol/L, AG 14.9, beta-hydroxybutyrate 0.5mmol/L), hyponatremia (Na 131mmol/L), hypochloremia (Cl 95.3mmol/L), elevated CRP (19.49), elevated d-dimer (0.5), elevated ferritin (714.4), and negative lactate. ABG on 2LPM via nasal cannula revealed hypoxic respiratory failure (pH 7.46, pCO2 34, pO2 62). COVID test was POSITIVE. CXR revealed multifocal peripheral patchy airspace opacities. Blood cultures were obtained. Patient was given LR x 1L, acetaminophen 1000mg IV x 1, and ondansetron 4mg IVP x 2. He was admitted to ICU for further care. Update of present Illness: 1/3/2022 - Remdesivir and dexamethasone were initiated. Levofloxacin was initiated for empiric CAP coverage. BIPAP was placed on 12/30/2021. FiO2 requirements have increased to 100%. Patient is BIPAP dependent this AM. 1/4/2022 - Remdesivir and levofloxacin completed. Dexamethasone continued. Patient remains BIPAP dependent this AM. Dexmedetomidine initiated for agitation with improvement in symptoms.  1/5/2022 - Patient desaturates with the removal of BIPAP.  Transition to comfort care is being considered. 1/6/2022 - Patient was transitioned to comfort care. Morphine IVP initiated. BIPAP removed. Patient progressed to asystole at 1240.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Positive airway pressure therapy, Respiratory failure, SARS-CoV-2 test positive, Serum ferritin increased, Tachycardia
Clinical narrative: Narrative:  Patient presented to the ED via EMS on 12/29/2021 with a chief complaint of vomiting x 24 hours. He reported testing positive for COVID on a home test. Symptoms began about 12/26/2021. EMS reported normal blood glucose and atrial fibrillation with HR sustaining in 120s. On arrival to our ED, Patient was saturating 86% on room air He was febrile (T 99.8) and tachycardic (HR 127). Labs in ED revealed leukopenia (WBC 2.80), thrombocytopenia (PLT 92), mild DKA (Glu 222mg/dL, bicarb 20.8mmol/L, AG 14.9, beta-hydroxybutyrate 0.5mmol/L), hyponatremia (Na 131mmol/L), hypochloremia (Cl 95.3mmol/L), elevated CRP (19.49), elevated d-dimer (0.5), elevated ferritin (714.4), and negative lactate. ABG on 2LPM via nasal cannula revealed hypoxic respiratory failure (pH 7.46, pCO2 34, pO2 62). COVID test was POSITIVE. CXR revealed multifocal peripheral patchy airspace opacities. Blood cultures were obtained. Patient was given LR x 1L, acetaminophen 1000mg IV x 1, and ondansetron 4mg IVP x 2. He was admitted to ICU for further care. Update of present Illness: 1/3/2022 - Remdesivir and dexamethasone were initiated. Levofloxacin was initiated for empiric CAP coverage. BIPAP was placed on 12/30/2021. FiO2 requirements have increased to 100%. Patient is BIPAP dependent this AM. 1/4/2022 - Remdesivir and levofloxacin completed. Dexamethasone continued. Patient remains BIPAP dependent this AM. Dexmedetomidine initiated for agitation with improvement in symptoms.  1/5/2022 - Patient desaturates with the removal of BIPAP.  Transition to comfort care is being considered. 1/6/2022 - Patient was transitioned to comfort care. Morphine IVP initiated. BIPAP removed. Patient progressed to asystole at 1240.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Thrombocytopenia, Vomiting, White blood cell count decreased
Clinical narrative: Narrative:  Patient presented to the ED via EMS on 12/29/2021 with a chief complaint of vomiting x 24 hours. He reported testing positive for COVID on a home test. Symptoms began about 12/26/2021. EMS reported normal blood glucose and atrial fibrillation with HR sustaining in 120s. On arrival to our ED, Patient was saturating 86% on room air He was febrile (T 99.8) and tachycardic (HR 127). Labs in ED revealed leukopenia (WBC 2.80), thrombocytopenia (PLT 92), mild DKA (Glu 222mg/dL, bicarb 20.8mmol/L, AG 14.9, beta-hydroxybutyrate 0.5mmol/L), hyponatremia (Na 131mmol/L), hypochloremia (Cl 95.3mmol/L), elevated CRP (19.49), elevated d-dimer (0.5), elevated ferritin (714.4), and negative lactate. ABG on 2LPM via nasal cannula revealed hypoxic respiratory failure (pH 7.46, pCO2 34, pO2 62). COVID test was POSITIVE. CXR revealed multifocal peripheral patchy airspace opacities. Blood cultures were obtained. Patient was given LR x 1L, acetaminophen 1000mg IV x 1, and ondansetron 4mg IVP x 2. He was admitted to ICU for further care. Update of present Illness: 1/3/2022 - Remdesivir and dexamethasone were initiated. Levofloxacin was initiated for empiric CAP coverage. BIPAP was placed on 12/30/2021. FiO2 requirements have increased to 100%. Patient is BIPAP dependent this AM. 1/4/2022 - Remdesivir and levofloxacin completed. Dexamethasone continued. Patient remains BIPAP dependent this AM. Dexmedetomidine initiated for agitation with improvement in symptoms.  1/5/2022 - Patient desaturates with the removal of BIPAP.  Transition to comfort care is being considered. 1/6/2022 - Patient was transitioned to comfort care. Morphine IVP initiated. BIPAP removed. Patient progressed to asystole at 1240.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, Neoplasm malignant, SARS-CoV-2 test positive, Terminal state
Clinical narrative: Narrative:  79yo male patient with a h/o melanoma on keytruda, s/p 4x stroke (last 2020) with expressive aphasia, colon cancer s/p partial colectomy, DMII, HTN, HLD, carotid artery stenosis, GERD, and OSA who presented to ER on 11/20/21 with 6 weeks of weakness since starting keytruda. Pt has been having progrssive side effects, including generalized itching, nausea vomiting, aches, and finally generalized weakness. Pt presented to ER on 11/20/2021 after a fall at home. Pt was admitted. Pt received his first covid while inpatient on 11/23/2021. On 11/22/21 chest xray suspicious for pneumonia. Of note covid test negative on admission (11/20/21). Pt was given and completed abx course for aspiration pna. On 12/1/21 pt was discharged to short term rehab. On 12/21/21 pt sent from rehab to ER for evaluation. Pt tested positive for covid infection. Pt had planned to discharge home from rehab to home hospice given cancer diagnosis on 12/22/21. Pt transferred to inpatient hospice. Pt died on 12/23/2021 during inpatient hospice admission. Pt did receive a covid vaccine on 11/23/2021 & tested positive for covid on 12/21/21. Pt also had terminal cancer diagnosis with plans for hospice care. Difficult to determine actual cause of patient's death. Possibly covid vaccine contributed to this patient's death.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Anticoagulant therapy, Aortic arteriosclerosis, Atelectasis, COVID-19
Clinical narrative: Narrative:  Admitted JAN 3,2022@21:01:20 Discharged JAN 11,2022@16:07 Assessment: 1. Acute-on-Chronic Diastolic Heart Failure 2. Acute Hypoxic Respiratory Failure 3. CKD Stage 3 67 yo male with PMH HTN, HLD, recently ESRD on HD (6/21-8/21) but now CKD 3a, DM, h/o prostate cancer, s/p right 2nd/3rd toe amputations, and left foot osteomyelitis, former smoker who presented to the Emergency Dept on 1/3/22 with worsening bilateral lower extremity edema and shortness of breath in setting of COVID complicated by acute hypoxic respiratory failure. He was admitted with Acute hypoxic respiratory failure secondary to COVID (Despite being COVID vaccinated x 2) with volume overload. Continued on home Lasix PO 40 mg BID. Completed Rocephin 1/8/2022 for CAP coverage. Completed 5 day course of remdesivir and dexamethasone and anticoagulated with Intermediate dose anticoagulation. Required 2L NC. Walk test on 1/10 with desat to 86% pm RA. Arranged for home O2 on discharge.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiac failure acute, Cardiomegaly, Chest X-ray abnormal, Chronic kidney disease, Dyspnoea
Clinical narrative: Narrative:  Admitted JAN 3,2022@21:01:20 Discharged JAN 11,2022@16:07 Assessment: 1. Acute-on-Chronic Diastolic Heart Failure 2. Acute Hypoxic Respiratory Failure 3. CKD Stage 3 67 yo male with PMH HTN, HLD, recently ESRD on HD (6/21-8/21) but now CKD 3a, DM, h/o prostate cancer, s/p right 2nd/3rd toe amputations, and left foot osteomyelitis, former smoker who presented to the Emergency Dept on 1/3/22 with worsening bilateral lower extremity edema and shortness of breath in setting of COVID complicated by acute hypoxic respiratory failure. He was admitted with Acute hypoxic respiratory failure secondary to COVID (Despite being COVID vaccinated x 2) with volume overload. Continued on home Lasix PO 40 mg BID. Completed Rocephin 1/8/2022 for CAP coverage. Completed 5 day course of remdesivir and dexamethasone and anticoagulated with Intermediate dose anticoagulation. Required 2L NC. Walk test on 1/10 with desat to 86% pm RA. Arranged for home O2 on discharge.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram abnormal, Hypervolaemia, Left ventricular failure, Lung opacity, Oedema peripheral
Clinical narrative: Narrative:  Admitted JAN 3,2022@21:01:20 Discharged JAN 11,2022@16:07 Assessment: 1. Acute-on-Chronic Diastolic Heart Failure 2. Acute Hypoxic Respiratory Failure 3. CKD Stage 3 67 yo male with PMH HTN, HLD, recently ESRD on HD (6/21-8/21) but now CKD 3a, DM, h/o prostate cancer, s/p right 2nd/3rd toe amputations, and left foot osteomyelitis, former smoker who presented to the Emergency Dept on 1/3/22 with worsening bilateral lower extremity edema and shortness of breath in setting of COVID complicated by acute hypoxic respiratory failure. He was admitted with Acute hypoxic respiratory failure secondary to COVID (Despite being COVID vaccinated x 2) with volume overload. Continued on home Lasix PO 40 mg BID. Completed Rocephin 1/8/2022 for CAP coverage. Completed 5 day course of remdesivir and dexamethasone and anticoagulated with Intermediate dose anticoagulation. Required 2L NC. Walk test on 1/10 with desat to 86% pm RA. Arranged for home O2 on discharge.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pleural effusion, Pulmonary oedema, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Admitted JAN 3,2022@21:01:20 Discharged JAN 11,2022@16:07 Assessment: 1. Acute-on-Chronic Diastolic Heart Failure 2. Acute Hypoxic Respiratory Failure 3. CKD Stage 3 67 yo male with PMH HTN, HLD, recently ESRD on HD (6/21-8/21) but now CKD 3a, DM, h/o prostate cancer, s/p right 2nd/3rd toe amputations, and left foot osteomyelitis, former smoker who presented to the Emergency Dept on 1/3/22 with worsening bilateral lower extremity edema and shortness of breath in setting of COVID complicated by acute hypoxic respiratory failure. He was admitted with Acute hypoxic respiratory failure secondary to COVID (Despite being COVID vaccinated x 2) with volume overload. Continued on home Lasix PO 40 mg BID. Completed Rocephin 1/8/2022 for CAP coverage. Completed 5 day course of remdesivir and dexamethasone and anticoagulated with Intermediate dose anticoagulation. Required 2L NC. Walk test on 1/10 with desat to 86% pm RA. Arranged for home O2 on discharge.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  75yo make patient deceased on 1/7/2022 at hospital. Pt was in dialysis when he passed. Pt presented to this hospital ER on 1/4/2021/ Patient self-presented to community emergency facility Emergency Notification Intake Date Presenting to the Facility: 1/4/2022 Community Care Hospital Name: Chief Complaint: Pneumonia Primary Diagnosis Patient Admitting Diagnosis: Pneumonia Community Care Provider: Acute Inpatient Care Problem list: Suspected urothelial cancer Dependence on hemodialysis due to end stage renal disease CHF - Congestive Heart Failure Legal blindness Seen by palliative care medicine serviceChronic kidney disease stage 4 Urinary incontinence Cardiac pacemaker in situ PVD-peripheral vascular disease Neuropathy due to type 2 diabetes mellitus Chronic obstructive lung disease Sleep Apnea Postraumatic stress disorder Benign essential hypertension Diabetes Mellitus Hypothyroidism Major Depressive disorder Hyperlipidemia ?Pt had received covid vaccines on 3/12/2021 & 4/9/2021 from another hospital site. Not sure id pneumonia was confirmed as diagnosis and if bacterial or if pt was covid positive since records of death at hospital.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  70yo male patient with the following problem list: Carbuncle of perineum (ICD-10-CM 1/31/2019 L02.235) Insomnia (ICD-10-CM G47.00) 09/05/2018 Hyperlipidemia (ICD-10-CM E78.5) 07/07/2017 Type 2 diabetes mellitus well controlled (ICD-10-CM E11.9) Hypertensive disorder (ICD-10-CM 12/29/2016 I10.) Noncompliance with medication regimen (ICD-10-CM Z91.14) Upper respiratory infection 06/01/2015 (ICD-9-CM 465.9) Sinusitis (ICD-9-CM 461.9) 06/01/2015 Cough (ICD-9-CM 786.2) 06/01/2015 Heel pain (ICD-9-CM 729.5) 06/01/2015 Plantar fasciitis (ICD-10-CM 07/07/2017 M72.2) History of polyp of colon 07/07/2017 (ICD-10-CM Z86.010) Depressive Disorder NOS 02/16/2017 (ICD-10-CM F33.42) Degeneration of intervertebral disc (ICD-9-CM 06/15/2006 722.6) Received one covid vaccine on 2/8/2021. Pt died of unknown causes & unknown place or circumstances on 3/21/2021. Unable to assess if vaccine related to this death. No notes in chart about pt's death.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 83 yo male received covid vaccines on 2/5/2021 & 3/9/2021. Past Medical History: hx carcinoid resected duodenum Gastroesophageal reflux disease Hyperlipidemia Neck pain Bilateral arthritis of knees Aneurysm of right iliac artery Abdominal aortic aneurysm without rupture Hyperlipidemia  Abdominal pain  Generalized headace  Urticarial rash  Angioedema of lips  Acute lower urinary infection  Urolithiasis  Multiple nodules of lung  Low back pain (ICD-9-CM 724.2) Renal mass (ICD-9-CM 593.9) Carcinoid tumor of intestine (ICD-9-CM2Chronic nonspecific abdominal pain Crohn's disease  Benign essential hypertension  Hyperlipidemia (ICD-9-CM 272.4) Health Maintenance (ICD-9-CM V65.9) Hearing loss (ICD-9-CM 389.9) Vision, Subnormal (ICD-9-CM 369.9) Osteoarthrosis involving the spine (ICD-RA notified pt died on 10/30/2021 - at nonRA facility Likely not related to covid vaccine This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest pain, Death, Feeling abnormal, Malaise
Clinical narrative: Narrative:  73yo male patient presented to ER on 12/19/2021 with hx of htn, hld, cad, MV disease (replaced) and copd). Generally weak and needs assistance from his wife at baseline. Diagnosed with covid 9 days ago, did not meet criteria for monoclonal antibodies at that time. Now feels worse with generalized malaise and myalgia. Pt had received one covid vaccine (J&J) on 3/16/2021. Pt with O2 sats 100% so still did not meet criteria for monoclonal ABXs. On 12/22/2021 pt presented to non facility ER. Patient self-presented to community emergency facility Emergency Notification Intake Date Presenting to the Facility: 12/22/2021 Community Care Hospital Chief complaint: Chest pain Primary Diagnosis: - PMH: Arteriosclerotic heart disease (Hyperlipidemia) Benign essential hypertension Degeneration of lumbar intervertebral disc Arthritis Mitral valve regurgitation Vitamin B 12 Deficiency (ICD-9-CM 266.2) Mitral Valve Insufficiency (ICD-9-CM 424.0) Hypertension, Essential (ICD-9-CM 401.9)Impotence of organic origin (ICD-9-CM 607.84) Personal History of Tobacco Use (ICD-9-C Moderate chronic obstructive pulmonary disease CAD (ICD-9-CM 414.9 HYPERLIPIDEMIA (ICD-9-CM 272.4) DDD-DISC DEGENERATION DISORDER (ICD-9-CM OSTEOARTHROSIS, GENERALIZED (ICD-9-CM 715.00) -- Date & Time of Death-- 12/22/2021@2238 --Location of Death-- HOSPITAL Cause of death not defined if chest pain was cardiac or covid pneumonia since pt was covid positive. Given pt's death was on same day of ER presentation at hospital ER, likely was a heart attack. Note, J&J vaccine failure as pt contracted covid infection after vaccinated.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Myocardial infarction, SARS-CoV-2 test positive, Vaccination failure
Clinical narrative: Narrative:  73yo male patient presented to ER on 12/19/2021 with hx of htn, hld, cad, MV disease (replaced) and copd). Generally weak and needs assistance from his wife at baseline. Diagnosed with covid 9 days ago, did not meet criteria for monoclonal antibodies at that time. Now feels worse with generalized malaise and myalgia. Pt had received one covid vaccine (J&J) on 3/16/2021. Pt with O2 sats 100% so still did not meet criteria for monoclonal ABXs. On 12/22/2021 pt presented to non facility ER. Patient self-presented to community emergency facility Emergency Notification Intake Date Presenting to the Facility: 12/22/2021 Community Care Hospital Chief complaint: Chest pain Primary Diagnosis: - PMH: Arteriosclerotic heart disease (Hyperlipidemia) Benign essential hypertension Degeneration of lumbar intervertebral disc Arthritis Mitral valve regurgitation Vitamin B 12 Deficiency (ICD-9-CM 266.2) Mitral Valve Insufficiency (ICD-9-CM 424.0) Hypertension, Essential (ICD-9-CM 401.9)Impotence of organic origin (ICD-9-CM 607.84) Personal History of Tobacco Use (ICD-9-C Moderate chronic obstructive pulmonary disease CAD (ICD-9-CM 414.9 HYPERLIPIDEMIA (ICD-9-CM 272.4) DDD-DISC DEGENERATION DISORDER (ICD-9-CM OSTEOARTHROSIS, GENERALIZED (ICD-9-CM 715.00) -- Date & Time of Death-- 12/22/2021@2238 --Location of Death-- HOSPITAL Cause of death not defined if chest pain was cardiac or covid pneumonia since pt was covid positive. Given pt's death was on same day of ER presentation at hospital ER, likely was a heart attack. Note, J&J vaccine failure as pt contracted covid infection after vaccinated.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, SARS-CoV-2 test positive, Syncope
Clinical narrative: Narrative:  Patient tested positive on 12/27/2021 and hospitalized despite one time J&J vaccine on 05/14/2021, no booster received to date. COVID-19 symptom of dry cough began 8-9 days prior to admission for syncope. No monoclonal antibody treated utilized.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Malaise, Myalgia
Clinical narrative: Myalgia "tired and sick" Narrative:
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Chest pain, Computerised tomogram thorax abnormal, Dyspnoea, Electrocardiogram
Clinical narrative: Within 10 days of receiving the second Maderna vaccinations I began having chest pain and shortness of breath. I was rushed to ER after vivisiting a walk-in health clininc when they determined I had acute pulmonary embolism. After a CT scan it was determined that I had many blood clots in both my right and my left lung, my right ventricle of my heart was enlarged from the strain of poor oxygen levels. I was gasping for air. While in the hospital I was given injections of Warfarin twice daily and After four days in the hospital, I was released was a prescription of Eloquis 2x's daily and follow up with Pulmonologist and Cardiologist as well as a hemotologist.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Laboratory test, Oxygen saturation decreased, Pulmonary embolism, Pulmonary thrombosis, Right ventricular enlargement
Clinical narrative: Within 10 days of receiving the second Maderna vaccinations I began having chest pain and shortness of breath. I was rushed to ER after vivisiting a walk-in health clininc when they determined I had acute pulmonary embolism. After a CT scan it was determined that I had many blood clots in both my right and my left lung, my right ventricle of my heart was enlarged from the strain of poor oxygen levels. I was gasping for air. While in the hospital I was given injections of Warfarin twice daily and After four days in the hospital, I was released was a prescription of Eloquis 2x's daily and follow up with Pulmonologist and Cardiologist as well as a hemotologist.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Scan with contrast abnormal, Thrombosis
Clinical narrative: Within 10 days of receiving the second Maderna vaccinations I began having chest pain and shortness of breath. I was rushed to ER after vivisiting a walk-in health clininc when they determined I had acute pulmonary embolism. After a CT scan it was determined that I had many blood clots in both my right and my left lung, my right ventricle of my heart was enlarged from the strain of poor oxygen levels. I was gasping for air. While in the hospital I was given injections of Warfarin twice daily and After four days in the hospital, I was released was a prescription of Eloquis 2x's daily and follow up with Pulmonologist and Cardiologist as well as a hemotologist.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Angina pectoris, Dizziness, Loss of consciousness, Nausea, Pallor
Clinical narrative: Patient turned pale after 5-10 min of receiving the vaccine. He felt dizzy, his vision got blurry for a few seconds. He felt nauseous but did not vomit. His heart was hurting. EMTs arrived approximately 15-20 min after vaccine was given. At that time, patient seemed to lose consciousness but was responsive when spoken to. He was taken to the hospital.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Patient turned pale after 5-10 min of receiving the vaccine. He felt dizzy, his vision got blurry for a few seconds. He felt nauseous but did not vomit. His heart was hurting. EMTs arrived approximately 15-20 min after vaccine was given. At that time, patient seemed to lose consciousness but was responsive when spoken to. He was taken to the hospital.
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Tinnitus
Clinical narrative: Worsening tinnitus since booster 11/27/2021
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: dizziness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administration date 15Feb2021 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: DIZZINESS (non-serious) with onset 20Feb2021, outcome "unknown", described as "dizziness". The event "dizziness" was evaluated at the physician office visit. Therapeutic measures were taken as a result of dizziness. Additional information: The patient was not on any medication other than a multivitamin. The patient's age was reported "55" (unit unknown). The patient took dimenhydrinate (DRAMAMINE) as a treatment but did not help. Her HCP recommended to probably not get the second dose if she is still experiencing the symptom.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Laboratory test, Lumbar puncture, Magnetic resonance imaging head, Magnetic resonance imaging neck, Miller Fisher syndrome
Clinical narrative: MILLER-FISHER SYNDROME; This spontaneous report was received from literature. This report concerned a 32 year old male of unknown race and ethnicity. The objective of the study was to describe the relationship between Covid 19 vaccination and Miller Fisher Syndrome. Miller-Fisher syndrome (MFS) is a rare variant, estimated to affect 1 to 2 in 1,000,000 cases of GBS (Guillain Barre Syndrome). The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: No significant medical history presented with progressive facial motor and sensory dysfunction. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number was not reported) 1 total, dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced miller-fisher syndrome and  presented with progressive facial motor and sensory dysfunction. He received the Johnson & Johnson COVID-19 vaccination 18 days prior. For three days, he had blurry vision, eye pain, and dysarthria. Then, over 24 hours, he became unable to smile and drink/eat due to facial weakness. In the Emergency Department, the patient was afebrile and hemodynamically stable. Lab work was unremarkable. Physical exam demonstrated significant facial diplegia including inability to fully close the eyes, raise the eyebrows, and smile. Magnetic Resonance Imaging and Magnetic Resonance Angiogram head and neck did not reveal any abnormalities. The patient underwent lumbar puncture which revealed an albumino cytologic dissociation with negative cultures and antibodies against GQ1B. The patient was monitored in the ICU (intensive care unit) and improved with IVIg (Intravenous immune globulin).  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovered from miller-fisher syndrome. The authors emphasized that at this time, The link between COVID-19 and GBS remains uncertain and clinicians should avoid drawing associations between both, but should remain vigilant in their practice, especially in recently immunized patients. The benefits of vaccination continue to far outweigh the small risk of GBS.(Guillain Barre Syndrome). This report was serious (Hospitalization Caused / Prolonged, and Life Threatening).; Sender's Comments: V0 20220117568-COVID-19 VACCINE AD26.COV2.S-myocarditis. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Sex: M
Vaccine: COVID19
Symptoms: Physical examination
Clinical narrative: MILLER-FISHER SYNDROME; This spontaneous report was received from literature. This report concerned a 32 year old male of unknown race and ethnicity. The objective of the study was to describe the relationship between Covid 19 vaccination and Miller Fisher Syndrome. Miller-Fisher syndrome (MFS) is a rare variant, estimated to affect 1 to 2 in 1,000,000 cases of GBS (Guillain Barre Syndrome). The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: No significant medical history presented with progressive facial motor and sensory dysfunction. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number was not reported) 1 total, dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced miller-fisher syndrome and  presented with progressive facial motor and sensory dysfunction. He received the Johnson & Johnson COVID-19 vaccination 18 days prior. For three days, he had blurry vision, eye pain, and dysarthria. Then, over 24 hours, he became unable to smile and drink/eat due to facial weakness. In the Emergency Department, the patient was afebrile and hemodynamically stable. Lab work was unremarkable. Physical exam demonstrated significant facial diplegia including inability to fully close the eyes, raise the eyebrows, and smile. Magnetic Resonance Imaging and Magnetic Resonance Angiogram head and neck did not reveal any abnormalities. The patient underwent lumbar puncture which revealed an albumino cytologic dissociation with negative cultures and antibodies against GQ1B. The patient was monitored in the ICU (intensive care unit) and improved with IVIg (Intravenous immune globulin).  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovered from miller-fisher syndrome. The authors emphasized that at this time, The link between COVID-19 and GBS remains uncertain and clinicians should avoid drawing associations between both, but should remain vigilant in their practice, especially in recently immunized patients. The benefits of vaccination continue to far outweigh the small risk of GBS.(Guillain Barre Syndrome). This report was serious (Hospitalization Caused / Prolonged, and Life Threatening).; Sender's Comments: V0 20220117568-COVID-19 VACCINE AD26.COV2.S-myocarditis. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).